SE0303570L - Fukt-känslig medicinsk produkt - Google Patents

Fukt-känslig medicinsk produkt

Info

Publication number
SE0303570L
SE0303570L SE0303570A SE0303570A SE0303570L SE 0303570 L SE0303570 L SE 0303570L SE 0303570 A SE0303570 A SE 0303570A SE 0303570 A SE0303570 A SE 0303570A SE 0303570 L SE0303570 L SE 0303570L
Authority
SE
Sweden
Prior art keywords
moisture
medical product
sensitive medical
sensitive
product
Prior art date
Application number
SE0303570A
Other languages
English (en)
Other versions
SE0303570D0 (sv
Inventor
Thomas Nilsson
Mattias Myrman
Sven Calander
Alf Niemi
Original Assignee
Microdrug Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30772321&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0303570(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE0303269A external-priority patent/SE0303269L/sv
Application filed by Microdrug Ag filed Critical Microdrug Ag
Priority to SE0303570A priority Critical patent/SE0303570L/sv
Publication of SE0303570D0 publication Critical patent/SE0303570D0/sv
Priority to US10/834,037 priority patent/US20050121027A1/en
Priority to EP04801709A priority patent/EP1691781A1/en
Priority to PCT/SE2004/001792 priority patent/WO2005053646A1/en
Priority to CA002548072A priority patent/CA2548072A1/en
Priority to AU2004294888A priority patent/AU2004294888B2/en
Publication of SE0303570L publication Critical patent/SE0303570L/sv
Priority to US11/448,765 priority patent/US20070104655A1/en
Priority to US12/235,803 priority patent/US20090013998A1/en
Priority to US12/417,795 priority patent/US20090188496A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
SE0303570A 2003-12-03 2003-12-22 Fukt-känslig medicinsk produkt SE0303570L (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0303570A SE0303570L (sv) 2003-12-03 2003-12-22 Fukt-känslig medicinsk produkt
US10/834,037 US20050121027A1 (en) 2003-12-03 2004-04-29 Inhalable tiotropium and container therefor
AU2004294888A AU2004294888B2 (en) 2003-12-03 2004-12-02 Inhalable tiotropium and container therefor
CA002548072A CA2548072A1 (en) 2003-12-03 2004-12-02 Inhalable tiotropium and container therefor
PCT/SE2004/001792 WO2005053646A1 (en) 2003-12-03 2004-12-02 Inhalable tiotropium and container therefor
EP04801709A EP1691781A1 (en) 2003-12-03 2004-12-02 Inhalable tiotropium and container therefor
US11/448,765 US20070104655A1 (en) 2003-12-03 2006-06-08 Inhalable tiotropium and container therefor
US12/235,803 US20090013998A1 (en) 2003-12-03 2008-09-23 Inhalable tiotropium and container therefor
US12/417,795 US20090188496A1 (en) 2003-12-03 2009-04-03 Inhalable tiotropium and container therefor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0303269A SE0303269L (sv) 2003-12-03 2003-12-03 Medicinsk produkt
SE0303570A SE0303570L (sv) 2003-12-03 2003-12-22 Fukt-känslig medicinsk produkt

Publications (2)

Publication Number Publication Date
SE0303570D0 SE0303570D0 (sv) 2003-12-22
SE0303570L true SE0303570L (sv) 2005-06-04

Family

ID=30772321

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303570A SE0303570L (sv) 2003-12-03 2003-12-22 Fukt-känslig medicinsk produkt

Country Status (6)

Country Link
US (4) US20050121027A1 (sv)
EP (1) EP1691781A1 (sv)
AU (1) AU2004294888B2 (sv)
CA (1) CA2548072A1 (sv)
SE (1) SE0303570L (sv)
WO (1) WO2005053646A1 (sv)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7080644B2 (en) * 2000-06-28 2006-07-25 Microdose Technologies, Inc. Packaging and delivery of pharmaceuticals and drugs
PL2083007T3 (pl) * 2003-11-03 2013-09-30 Boehringer Ingelheim Int Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
PT1682541E (pt) * 2003-11-03 2010-04-14 Boehringer Ingelheim Int Processo para a preparação de sais de tiotrópio
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303569L (sv) * 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
JP2007512898A (ja) * 2003-12-03 2007-05-24 マイクロドラッグ アクチェンゲゼルシャフト 湿度に過敏な薬剤向けの予め計量されたドライパウダー吸入器
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
WO2005053647A1 (en) * 2003-12-03 2005-06-16 Microdrug Ag Medical product containing tiotropium
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
US8474452B2 (en) 2004-02-24 2013-07-02 Microdose Therapeutx, Inc. Directional flow sensor inhaler
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
EP2486942B1 (en) 2004-11-24 2018-10-10 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
JP2009504604A (ja) * 2005-08-06 2009-02-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 重症持続型喘息の治療におけるチオトロピウム塩の使用
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
CA2634984C (en) * 2006-01-04 2014-05-06 Boehringer Ingelheim International Gmbh Use of tiotropium salts in the treatment of moderate persistent asthma
FI20065636A0 (sv) * 2006-10-04 2006-10-04 Lab Pharma Ltd Desikantsystem för reglering av inhalerbara pulvers fuktighet
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
WO2009046215A2 (en) * 2007-10-02 2009-04-09 Lab International Srl Safety and abuse deterrent improved device
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
US8371294B2 (en) 2008-02-29 2013-02-12 Microdose Therapeutx, Inc. Method and apparatus for driving a transducer of an inhalation device
EP2400950B1 (en) 2009-02-26 2019-05-22 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
EP2432536B1 (en) * 2009-05-21 2018-07-04 MicroDose Therapeutx, Inc. Rotary cassette system for dry powder inhaler
US8985101B2 (en) 2009-05-21 2015-03-24 Microdose Therapeutx, Inc. Method and device for clamping a blister within a dry powder inhaler
US20110000481A1 (en) * 2009-07-01 2011-01-06 Anand Gumaste Nebulizer for infants and respiratory compromised patients
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
TR201000680A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
TR200909788A2 (tr) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
TWI589313B (zh) 2010-01-05 2017-07-01 麥可朵斯斯若波特公司 醫藥遞送封裝及吸入器
WO2011152804A2 (en) * 2010-06-03 2011-12-08 Mahmut Bilgic Process for dry powder formulations
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US10111957B2 (en) 2012-07-05 2018-10-30 Arven Ilac Snayi ve Ticaret A.S. Inhalation compositions comprising glucose anhydrous
US10105316B2 (en) * 2012-07-05 2018-10-23 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising muscarinic receptor antagonist
FR2997168B1 (fr) * 2012-10-19 2018-09-14 Valeo Systemes Thermiques Dissipateur thermique, module chauffant associe et procede d'assemblage correspondant
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
EA201790833A1 (ru) 2014-10-16 2017-09-29 Тева Брэндид Фармасьютикал Продактс Ар Энд Ди, Инк. Сухой порошкоообразный состав
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
WO2018071443A1 (en) 2016-10-11 2018-04-19 Microdose Therapeutx, Inc. Inhaler and methods of use thereof
WO2020245147A1 (en) * 2019-06-03 2020-12-10 Amcor Flexibles Singen Gmbh Process for the conditioned packaging of hard gelatin capsules
GR1010358B (el) * 2021-09-14 2022-12-16 Elpen Ανωνυμος Εταιρεια Φαρμακευτικη Βιομηχανια, Σταθερο φαρμακευτικο σκευασμα που περιεχει βρωμιουχο τιοτροπιο, για χορηγηση απο το αναπνευστικο

Family Cites Families (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1052068A (sv) * 1963-11-04
GB1521000A (en) * 1975-06-13 1978-08-09 Syntex Puerto Rico Inc Inhalation device
DE2540633A1 (de) * 1975-09-12 1977-04-28 Boehringer Sohn Ingelheim Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
PH24267A (en) * 1980-02-15 1990-05-29 Glaxo Group Ltd Androstane carbothioates and pharmaceutical compositions containing the same
DE3274065D1 (de) * 1981-07-08 1986-12-11 Draco Ab Powder inhalator
DE3211185A1 (de) * 1982-03-26 1983-09-29 Boehringer Ingelheim KG, 6507 Ingelheim Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung
DE3215493A1 (de) * 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung
CA1224992A (en) * 1982-10-08 1987-08-04 Robert E. Newell Device for administering medicament to patients
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US5270305A (en) * 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
SK280967B6 (sk) 1990-03-02 2000-10-09 Glaxo Group Limited Inhalačný prístroj
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US5192548A (en) * 1990-04-30 1993-03-09 Riker Laboratoires, Inc. Device
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5770738A (en) * 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
US5785049A (en) * 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
FR2698289B1 (fr) 1992-11-20 1995-01-27 Airsec Ind Sa Matières déshydratantes à base de polymères.
US5888477A (en) * 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
SE9400335D0 (sv) * 1994-02-02 1994-02-02 Astra Ab Powder mixing
US5544647A (en) * 1994-11-29 1996-08-13 Iep Group, Inc. Metered dose inhalator
US6130263A (en) 1995-04-19 2000-10-10 Capitol Specialty Plastics, Inc. Desiccant entrained polymer
DE19515625C2 (de) * 1995-04-28 1998-02-19 Boehringer Ingelheim Kg Verfahren zur Herstellung von enantiomerenreinen Tropasäureestern
US5714007A (en) 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
SE504458C2 (sv) * 1995-06-21 1997-02-17 Lars Gunnar Nilsson Inhalator för elektrisk dosering av substanser
US6209538B1 (en) 1995-08-02 2001-04-03 Robert A. Casper Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
EP0865302B1 (de) * 1995-12-07 2000-05-31 Jago Pharma Ag Inhalator zur mehrfachen dosisweisen abgabe eines pharmakologischen trockenpulvers
US5826633A (en) * 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
US5699649A (en) 1996-07-02 1997-12-23 Abrams; Andrew L. Metering and packaging device for dry powders
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
SE512386C2 (sv) * 1998-07-30 2000-03-06 Microdrug Ag Förfarande och anordning för klassificering av elektrostatiskt laddat pulverformigt material
GB9820746D0 (en) * 1998-09-23 1998-11-18 Pharmax Limited Micronised pharmaceutical compositions
EP1862164A3 (de) * 1998-11-13 2012-12-26 Jagotec AG Trockenpulver zur Inhalation
US6270869B1 (en) * 1998-12-02 2001-08-07 Alusuisse Technology & Management Ltd. Cold formable laminate films
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
ATE294608T1 (de) * 1999-06-05 2005-05-15 Innovata Biomed Ltd Verabreichungsystem für medikamente
AU777421B2 (en) * 1999-10-11 2004-10-14 Ml Laboratories Plc Medicament delivery device with moisture resistant coating
PL354621A1 (en) 1999-10-22 2004-02-09 Innovata Biomed Limited Dosage unit for dry powder medicament
SE517806C2 (sv) * 1999-11-11 2002-07-16 Microdrug Ag Doseringsanordning för inhalator
SE9904484L (sv) * 1999-12-08 2000-10-23 Microdrug Ag Förfarande och anordning för transport och blandning av ett fint pulver med en gas
SE9904706D0 (sv) * 1999-12-21 1999-12-21 Astra Ab An inhalation device
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0009468D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formulations for use in inhaler devices
DE60129222T2 (de) * 2000-05-11 2008-03-06 Consejo Superior de Investigaciónes Científicas Heterocyclischen inhibitoren von glycogen synthase kinase gsk-3
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
AR028746A1 (es) 2000-06-23 2003-05-21 Norton Health Care Ltd Cartucho de dosis previamente medidas para inhalador de polvo seco accionado por la respiracion, el inhalador y un metodo de provision de dosis previamente medidas de polvo seco
GB0015801D0 (en) 2000-06-28 2000-08-16 Innovata Biomed Ltd Cover
DE10046127A1 (de) 2000-09-15 2002-03-28 Hoefliger Harro Verpackung Verfahren zum Verfüllen von mikroisiertem Pulver und Vorrichtung zum Durchführen des Verfahrens
SE517225C2 (sv) * 2000-09-21 2002-05-14 Microdrug Ag Optimering av en elektrostatiskt doserad inhalator för torrt pulver
SE517227C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Inhalator för torrt pulver med folieskärare
SE517226C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Inhalator med luftbroms för torrt pulver
USD443689S1 (en) * 2000-09-25 2001-06-12 Microdrug Ag Inhalator
SE517513C2 (sv) * 2000-09-25 2002-06-11 Microdrug Ag Gränssnittsarragemang för att säkerställa korrekt dosering samt säker funktion och hantering vid en inhalator för torrt pulver.
ES2227268T3 (es) * 2000-10-12 2005-04-01 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Nuevos polvos para inhalacion con contenido en tiotropio.
US6608054B2 (en) * 2001-03-20 2003-08-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and endothelin antagonists
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020193393A1 (en) * 2001-03-07 2002-12-19 Michel Pairet Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20030158196A1 (en) * 2002-02-16 2003-08-21 Boehringer Ingelheim Pharma Gmbh Co. Kg Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6620438B2 (en) * 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
GB0026647D0 (en) * 2000-10-31 2000-12-13 Glaxo Group Ltd Medicament dispenser
GB0029362D0 (en) 2000-12-01 2001-01-17 Pa Consulting Services Particle dispense rate regulator
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) * 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
US20030013675A1 (en) 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10126924A1 (de) 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
SE522557C2 (sv) * 2001-07-13 2004-02-17 Microdrug Ag Förfarande och anordning för snabb neutralisering av ett skapat elektrostatiskt fält innefattande ett medicinskt pulver deponderad på en målarea vid en dosutformningsprocess
SE522558C2 (sv) * 2001-07-13 2004-02-17 Microdrug Ag Förfarande och anordning för styrning av överföring av elektriskt laddade partiklar av ett medicinskt pulver till en målarea på ett substratelement vid en dosutformningsprocess
US6949154B2 (en) * 2001-07-28 2005-09-27 Boehringer Ingelheim Pharma Kg Method and apparatus for sealing medicinal capsules
JP2004537377A (ja) * 2001-08-09 2004-12-16 グラクソ　グループ　リミテッド 製薬組成物を有する吸入装置
GB0120018D0 (en) 2001-08-16 2001-10-10 Meridica Ltd Pack containing medicament and dispensing device
GB0122935D0 (en) 2001-09-24 2001-11-14 Meridica Ltd Dispensing small quantities of particles
GB0122938D0 (en) 2001-09-24 2001-11-14 Meridica Ltd Loading and unloading a weighscale
US20030078947A1 (en) * 2001-10-12 2003-04-24 Intel Corporation Methods for assigning unique identifiers in a distributed fault tolerant application
US7258118B2 (en) * 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
GB0202538D0 (en) 2002-02-04 2002-03-20 Meridica Ltd Dispensing small quantities of particles
GB0202912D0 (en) 2002-02-07 2002-03-27 Meridica Ltd Method and apparatus for introducing powder into a pocket
GB2385020A (en) 2002-02-07 2003-08-13 Meridica Ltd Medicament container and method of manufacture thereof
US6591832B1 (en) * 2002-02-21 2003-07-15 Saint-Gobain Calmar Inc. Dry powder dispenser
UA80123C2 (en) 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
SE524957C2 (sv) * 2002-04-12 2004-11-02 Microdrug Ag Förfarande för uppdelning och fördelning i luft av torrt pulvermedikament
SE525027C2 (sv) * 2002-04-12 2004-11-16 Microdrug Ag Anordning utgörande en pulverlufthyvel
SE524990C2 (sv) * 2002-04-12 2004-11-09 Microdrug Ag Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
USD477665S1 (en) * 2002-06-12 2003-07-22 Microdrug Ag Inhaler
DE20209156U1 (de) 2002-06-13 2002-10-02 Hoefliger Harro Verpackung Vorrichtung zum dosierten Verfüllen von Behältnissen mit pulverförmigem Füllgut
GB0225621D0 (en) * 2002-11-02 2002-12-11 Glaxo Group Ltd Medicament carrier
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
ES2368488T3 (es) * 2003-05-15 2011-11-17 Covidien Ag Sellador de tejidos con miembros de tope variables de forma selectiva y no conductores.
SE527069C2 (sv) * 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
SE526850C2 (sv) * 2003-06-19 2005-11-08 Microdrug Ag Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
US20050055014A1 (en) * 2003-08-04 2005-03-10 Coppeta Jonathan R. Methods for accelerated release of material from a reservoir device
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303569L (sv) * 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
SE0402345L (sv) * 2004-09-24 2006-03-25 Mederio Ag Uppmätt läkemedelsdos

Also Published As

Publication number Publication date
US20090188496A1 (en) 2009-07-30
EP1691781A1 (en) 2006-08-23
AU2004294888A1 (en) 2005-06-16
CA2548072A1 (en) 2005-06-16
WO2005053646A1 (en) 2005-06-16
AU2004294888B2 (en) 2010-08-05
US20090013998A1 (en) 2009-01-15
SE0303570D0 (sv) 2003-12-22
US20050121027A1 (en) 2005-06-09
US20070104655A1 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
SE0303570L (sv) Fukt-känslig medicinsk produkt
DE602004002206D1 (de) Folienähnliches produkt
DE602005000476D1 (de) Extrudiertes Produkt
FI20030610A0 (sv) Ätbar produkt
NO20054681D0 (no) Farmasoytiske produkter
ATE466925T1 (de) Duftverfahren und produkt
ATE402248T1 (de) Wäschebehandlungsmittel
DK1932523T3 (da) Klæbende produkt indeholdende bisoprolol
DE602004002727D1 (de) Gesundheitsüberwachungsgerät
DE602006016866D1 (de) Thermoplastharzzusammensetzung und produkt daraus
DE602005019009D1 (de) Verzinntes Produkt
FIU20070081U0 (sv) Sanitetsprodukt
SE0301552L (sv) New product
DK1876916T3 (da) Produkt
SE0300002L (sv) Ny produkt
SE0203353L (sv) Korrugerad produkt
DE602004022402D1 (de) Extrusionsprozess und produkt
DK1658073T3 (da) Farmaceutisk produkt til injektion
DE502004005544D1 (de) Mikrodosiereinrichtung
SE0400246L (sv) Produkt med hydrofoba egenskaper
NO20034952D0 (no) Farmasöytiske forbindelser
DK1849774T3 (da) Cyclohepta(b)pyridin-3-carbonylguanidinderivat og farmaceutisk produkt indeholdende samme
ATE377058T1 (de) Pflegemittel
DK1418871T3 (da) Absorberende produkt
DK1691751T3 (da) Hygiejneprodukt